Teva to Discuss MS and Huntington’s Therapies at Premier Neurology Conference – Multiple Sclerosis News Today

Posted: Published on April 20th, 2017

This post was added by Dr Simmons

ksG(2g@7 Mz)RuFxE]ZA1~qo)KnfVuOjzfVe.I:[*~ #P48E_WqE9a$W/~%M+*00bA;'GMG";Fap*AlGT:(n0q?|yA%7qb;pDd:"#;]MmN``s_i;{|bEZ4|#WDY"'Q G5`#?k{ WF]MD[D,3|I;xN}o$B%mC6RKl[ 8~3]Il@eGf;#!aq&".m-IU_`[Tq-*3yx<2-/YLkkG( +iem :v4ulEZS~5?6nM55B ,/ovX,YI2NM8!6oMt;`s&Oh_R0w6s`XXQ!c/"X'~ g:! G(xkt=dR"6'{Rk4"~ l{* }~S~ w`<$VAB8@{H0d!m^amgJ>Y`U)t*CS}ui`_E(Klu/7#r V].1v#2SZA,&.?7fY7~nJAz#so? MQ9TV32;3?D@h@yK[z!jxTymX3?O Fi?qz_NsR<|UUuPyvS|PZ $|Z6p5Zooc}cW#'DkobWVu; 0kI{uxT,6n5>?a""hN96f8`fGn/aYo,G|NsF"QhX'-;yWB]ef-wY_AjX~lzAVYtb;V=jf>,B4^QtSToU+MhpU$*)Lo=JFGi /0`.b_.N4C6CLZ4L!B:1d6wtV{sy@kd4jPFqJxP dx>3T4h"Dlh n(Wi018 56RJBK),{r6cl~8oc#4_Cr`65lH9|2t:uY~kC}1BEIgI9w"%90o6$i'B/[Qr3q=whObk-+.F$0v/N*LI9rX* Fb%zs3G:Q}wWGL}%r)-e =:r2K cTP!Y7mlOey>D>/{g-Acn;5QTkNhy 9-y8?"jg_}@cz~}?['%(T7SWuW=/ 2Rj9*N%!<0$-L-K<^3,qh0RvEh 4ZH Y8-tQCjP0(3IUo#2>6cE8[rz:f'IaO"4FZ(]Up4;7v-qKv(F2G9@_ltO2Jdb'??2hYA(t qY`kGSbBLDt~(4)m/HwrD O]=hhOU,?(1NNix"7m/ %_T;rAY,"Xi~^aR#F&Y?`r+1 "o}.H7j$Ly; JZ/QCyKd}F#Ztt]1y `ls48k)%q|56TpuX("PXAv bjmmoM]Q8Rag3Brb3Ubj`_U79cbm*K*Z,er1c9O4D5VxsJ?X:Huuq ZlDabI=ZULUXR D6Xen_A}@ IZ suAM]R)(oOgJI-uy*YQ1*9~4!Z*;feuAWa|B% o1Nb^m_>5(%O4^;7~):.H[pr"?;:t2 5AZ $`MHf >{U6di] MB~i]??%`^kUi"hz|KL_%AqxnOhE90X+{v1^5**KdM<%k.T 6v ,m0ZhZyjR,Cc.:P74l*mZ'DCH,wznsr;ex~Cv@&cb'W`1%P)`xCphnc$3K@9 T,9BAv]CU::zZkn 5:HS* wBVpZcDJ6sCTf0 Qm[#$KS>Ued)CuS+BP6,`k.oO]bSjyS1"h~UDxqktm i7Zg1k gX1yb]h 9+&=,lK#fm;-a-s I#^UL;RhS@pGm=c6q|Y@:uVTbPcfhV J AM/ylminsRaaCy"LM5gcjo.z00$O,Hum/h#'V; CoG]WC7Zsd*w6_A1s'qMD tQ }0qS}F))j_jF`4Nnai!=r gB5=)#FrmZX$Jzc0fm;z;tFn7W7^a]jCCMTXpvOv,ry@3zn"yZ;tR{B)r Fy|# *BGeoe,%JxB%c_BiUJV'*gV_(ElV%-kk7x-Sa@nH1qU_{ i%@ jYLFlcf=BG2x;f6_W/$1dZpw}Aa>G,-57xO@-`FM:3.RTa=?$8*"f?k1Levnl=&1^x* w|raek9jk+)=6^#_1WL{JKUUO_^S@/OlpkmZGL'4`''YxYZ~JE.I{2C*,{C;Q9|[~{ /v 4fH_JBK(jp{ohQre[O5cXoLC4,oQ @j,x;;"2H{?&siH8+U,WS+6k5>Lhb?Y5WrZ%cAtM% m_r65v)>@6XtAeS(T&jPe# k,7loPw"29;qAs/]]*OU`iMAPw? 9Qk+gJdYMJf361h-LF Rj*ma~z0?ACO^oEBE!|+FesJD^7}k,ALbKtP q6R1G(s3s>fSK1(9AM"p(8`n` & 0&g8ygY-i=lDMMG`z6y8~|.s@tK%hr!AsCaW<;Z">;xY,k`k hN[>SmLM*GRqP.%e X; Vs$8~1@s-L.r'1MT8SUVVi|hj.1b4=nIxt"sY[VNULsK%q_gJ@z/) "X0qQ>kU`63a (_6w]Glfn/t^G,cj-F?0!0A/QkVv6KvSQ[cwd"s-hgEd)(A~(lp{Qki'9i f,r~zh^QL nGAx]V@@p?``lp{!|#QvgXXk)~ mx`_N6nv5f8!wwGK'OuN%JbZ|f`FsPbCWyn`Y3j1pSa8|jXb^U@`r6*)=g[hc "nE&Z9~oAa>aW7%wP=G|6f,MKCfp]JU$x5|8&pv,qq6M/vc@.sr/`jM6o-'euR1=Ba!BfVa&FW*w+e{[eGe}":FT n1mk^{zdl|Nl<,g-qs%V9*d9Z({PA9<*'/CTe,mlv1YEaO0lE'!1$%("#OXn-f_wQ([4 n[<^{IlOef4}K^rb+Hxdp4AQFGf=%o6b[} Q^_.N g(JC{C@M;,=2:15NcfMs{,~Pm es.vr_jo{yDZ+^a=';mX?.EB &;&/ ?Idq((5;%? R$>"'Y&0+Tlv}Xsp_(nhC641^f{3(d{}aaYV{:8G+bkbe.{hw{)]v~I)aP4rPk+a J>@ np+i0,qAQKuG0ADei]AOOwF=]E3YU]WkYhWXnfTr55C0Nn}h '%NaK4A'h#-CWNSsAv.&,[t"KLZ/z"a5X|b^^B yQ95}eS^R4%Ls7sP-IQ!t[QGe[,Psi~2r6S[{I6}hQ[=ag'X`ee>S&I14mS!| G~ZeP-17 R =LF% ]u'v+6M[Zro ndzx~x6zw=cMGlzfVwfEr7e3]n[]@%84gbK2Pz)%M nc<,y7$YT`@jpl@lQhPRY?n=.{)ocQ K]6mw.AeY"~-M7e-zkxmrKOS$ %tw%G)S|7|gAn(OC7ol[<)hZ~2xn*#pG2Qc.#ny)#M|#<[CMd8-= Q9dD[0"5FAD< ]&?Pt2T,>S^ [z'7} k~UVHdOMsc&p}q:h2xPx ^@Np8'K&F#!o#`a,euAeF b/~Wkmq^ 3'LG_12y=L"$-^y5&+Hmc 5Ar0k~| hRiJ-J)d_$r*0iPqNN^w2M@tPd~btB +NN>>nd6Hq AGhr!K 1-Z ?1l")# gxq {p E-M8q-.j$/DH:s!:M0|NPB qF'UQ(~I`i):ypG@^EGSh@^'|$ WRZb`E{N}%!%e,$b Hr]:nO,XbY))Mif4?ANk]3eAB,VMu,? 8Z;}H XeDyZg9FNBenXaZ *@M&jd*5?rq RNzzVd+*5Ucvd+dTGl=rQ<>n:y&gwuj @(`=6c~_;p( lj#j L5B}lAxgA]@M-|tS"w0m]*:euU1oMrfEE:LEPPXv{#}8=ntG-;~zgdmj>t0[WX4%*y' (6f_$W'zfmZTc+UTvivq>W.u](&h3Nrgb5*]5dgwHWOg~* vhoygsjYp{Y%b2=tzX/0o6XyQHE6&m`#XJ^7/=jw:z={!KEm]s|:,|>@^<@@}f-D_."q[ PB/?AqL2[;-=qSe>&? tHL=#Q)qbv,"3}NI&3nnyyDliqP9}rjjfJb0|!m41l9tf)lfM5l}EV,;|)K=v.-ZHpl X%1z<|9%Aw|/R%'Z,=;~% S&.ws6)Ao9Z!itDA_g(GeNPx !b7&-BwSa5hYfROcb:6Bl* 1.4o tk6+3>`L `B#(NBUrBEt JjEXVm1yEi6?>ilitwj `NZ *ha"3$mCH^x K:FvTr6x!{3<_2v)XFFJ=Hhd}CYCa E/$C*X5WO0e0>V0q]GdQ&%=k:@lOG{Z(97JS-84S,/{cou6$gj:C<8?HTilN4|f:j`{8M{zNJzeK8[Tkwcz{O*o^-6VWzkgcB1"9FHJN58KP"IN%`qJ1eHt;d:rDlW`)'qi5tq72E[@WcL^rfRaPR@SyME@Y Z4!C:&$pFuTl0}K4W7H9hA9q^k`3k^SB|]C?GtV [|!N`-`D"g;,6Em9`rPNqymqRQ U2tbxod(E2fK|!>`x+)(0/O9:bNG2.UNS54eP=&dw(Ag@-xX}E;eQJdCwi:) |!;b GI iIeG{e1J!&1 eVSH^4"D[sL{>U*"e.XP~I :wK EZfHRQp?- =:R;#;mPgK~]fZ P-`r-F|QiID4zO6*@&@c$PJ{%EJ^Q^RL]K7^-acm*5AGmivV}.VaR/Onq>c,7/` sEZEF')Gz2|39o|2n4#wGvrvgR~$.( .=-?s)Y@)|'B-;_^Srb(*9Yk,+$aq+OLp9LWN{yFIbzC}:M)L}hH/IFpVUG-AuvAh#!,yPi!y$fN!_U :ZM?c?c?klFvl-Vu :O'(#'Hc^p*TE:v^+SxNFtJ}Is)owyD h+7%YkK}pm4&L`|w rNf{Bk*lnB{1 [E+:yzevlYB)xjGZ3} EN8K xs7 _FAa>[|!_^D8m%oHx Nbza$O'BBv6L#| g> Wm:@&$E./e;/}@_Na?YnBpp}No0HQ($5 r>U~?(nA6!A4l.U,ZBJ6X>U|`S4 IhCL.s)gNgo+sgo`:02{{+>7,9$:. gA=b:IlY3HPYXNWrN;C`iKBDq.;{!9@zP?Us)"%HFu=XIN_'7S^AJGx"HjKefTx@GT^Pw5p0srz qpQQyin?cSZ~s#v qAS`8FStxa$>hfu M|`Ccu9ge_Q:z w<%PW5uT!oS(}kh)/4|6* #B@bSo.y jHD~_LAG"Msblq6s bgx) w=;C4#/?|OXE;1^7tRom+CtMZAZlt#5H)

The rest is here:
Teva to Discuss MS and Huntington's Therapies at Premier Neurology Conference - Multiple Sclerosis News Today

Related Posts
This entry was posted in MS Treatment. Bookmark the permalink.

Comments are closed.